Documents
-
- Download
- Title Pages_Contents
- open access
-
- Download
- Chapter 2
- open access
- Full text at publishers site
-
- Download
- Chapter 3
- open access
- Full text at publishers site
-
- Download
- Summary in English
- open access
-
- Download
- Summary in Dutch
- open access
-
- Download
- Publications_Curriculum Vitae
- open access
-
- Download
- Propositions
- open access
-
- Download
- Link to published article Chapter 4
- open access
In Collections
This item can be found in the following collections:
Osteosarcoma : searching for new treatment options
Osteosarcoma is the most frequent malignant bone tumor affecting mainly adolescents and people older than 50years old. Current treatment involves chemotherapy and surgical removal. Despite efforts to find a cure, there is 70% 5year survival rate. For patients that present metastasis at the moment of diagnosis, the prognosis is worse. Additionally, many do not respond well to chemotherapy.
The aim of this research was to find new treatment options for patients with osteosarcoma. I searched for inhibitors that could sensitize osteosarcoma cells to chemotherapy. In this thesis, it is shown that targeting cell cycle regulators, proteins involved in apoptosis inhibition, and cellular pathways involved in survival, proliferation and migration are promising candidates for further research.
- All authors
- Baranski Madrigal, Z.
- Supervisor
- Water, B. van de; Hogendoorn, P.; Bovée, J.
- Co-supervisor
- Danen, E.H.J.
- Committee
- Gelderblom, H.; Guchelaar, H.J.; Bouwstra, J.; Graaf, P.H. van der; Flanagan, A.
- Qualification
- Doctor (dr.)
- Awarding Institution
- Leiden Academic Centre for Drug Research (LACDR) , Science , Leiden University
- Date
- 2016-05-26
- ISBN
- 9789462954434